OBLN

Obalon Therapeutics, Inc.

Healthcare

Set alert

Price alert · OBLN

All alert types
3.05 0.00 0.00%
As of Jun 16, 2021
2.95 Day range 4.80

52-week range unavailable

Open
3.25
Prev close
3.05
Mkt cap
30.57M
Vol
26.47M
Avg vol
0
EPS
0.00
P/E
0.00
Div yield
0.00%
More statistics
Low
2.95
High
4.80
Forward P/E
-11.30
Beta
-1.24
Short ratio
0.08
Inst. own
31.70%
Dividend
0.00
Ex-div date
Earnings
Jul 29, 2021
50-d avg
9.14
200-d avg
9.08
1y target
6.15

5D chart

Chart tools
Interval

Chart is warming up

The five-day price history for OBLN has not been loaded yet. Try again in a moment.

Financial health

Altman Z-Score

-14.83 Distress zone

Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.

Piotroski F-Score

2 / 9 Weak

Nine pass/fail tests of profitability, leverage and efficiency.

Valuation

P/E 0.0×
FY 2014: -14.7×FY 2015: -8.7×FY 2016: -6.8×FY 2017: -3.2×FY 2018: -1.1×FY 2019: -0.4×FY 2020: -0.9×FY 2024: -0.2×FY 2025: 0.0×
FY 2014 5y median -0.4× FY 2025
P/S 0.0×
FY 2014: 41.1×FY 2015: 33.5×FY 2016: 40.8×FY 2017: 11.1×FY 2018: 4.3×FY 2019: 2.7×FY 2020: 7.3×FY 2024: 0.2×FY 2025: 0.0×
FY 2014 5y median 2.7× FY 2025
P/B 0.0×
FY 2014: -3.6×FY 2015: -2.5×FY 2016: 2.2×FY 2017: 3.1×FY 2018: 3.0×FY 2019: 0.6×FY 2020: 2.5×FY 2024: -6.2×FY 2025: 0.0×
FY 2014 5y median 0.6× FY 2025
P/FCF 0.0×
FY 2014: -14.3×FY 2015: -11.7×FY 2016: -7.0×FY 2017: -3.5×FY 2018: -1.3×FY 2019: -0.4×FY 2020: -1.1×FY 2024: -0.4×FY 2025: 0.0×
FY 2014 5y median -0.4× FY 2025
EV/EBITDA 0.5×
FY 2014: -14.7×FY 2015: -9.2×FY 2016: -3.8×FY 2017: -2.9×FY 2018: -0.8×FY 2019: 0.2×FY 2020: -1.6×FY 2024: 83.9×FY 2025: 0.5×
FY 2014 5y median 0.2× FY 2025
EV/Sales -15.5×
FY 2014: 40.5×FY 2015: 35.1×FY 2016: 22.9×FY 2017: 10.0×FY 2018: 3.1×FY 2019: -1.2×FY 2020: 11.4×FY 2024: 0.2×FY 2025: -15.5×
FY 2014 5y median 0.2× FY 2025
FCF Yield 0.0%
FY 2014: -7.0%FY 2015: -8.5%FY 2016: -14.3%FY 2017: -28.7%FY 2018: -77.9%FY 2019: -257.9%FY 2020: -90.8%FY 2024: -281.5%FY 2025: 0.0%
FY 2014 5y median -90.8% FY 2025

Profitability

Gross Margin 68.4%
FY 2014: 17.7%FY 2015: 38.0%FY 2016: 17.2%FY 2017: 51.3%FY 2018: 40.4%FY 2019: 10.1%FY 2020: 36.8%FY 2024: 63.2%FY 2025: 68.4%
FY 2014 5y median 40.4% FY 2025
Operating Margin -3237.8%
FY 2014: -278.0%FY 2015: -369.7%FY 2016: -574.9%FY 2017: -346.9%FY 2018: -406.2%FY 2019: -708.0%FY 2020: -670.2%FY 2024: -83.3%FY 2025: -3237.8%
FY 2014 5y median -670.2% FY 2025
Net Margin -3277.2%
FY 2014: -279.5%FY 2015: -385.2%FY 2016: -603.2%FY 2017: -350.7%FY 2018: -410.7%FY 2019: -721.6%FY 2020: -776.7%FY 2024: -89.1%FY 2025: -3277.2%
FY 2014 5y median -721.6% FY 2025
ROE -278.5%
FY 2014: 24.8%FY 2015: 28.2%FY 2016: -31.8%FY 2017: -99.0%FY 2018: -285.2%FY 2019: -149.4%FY 2020: -264.4%FY 2024: 2818.2%FY 2025: -278.5%
FY 2014 5y median -264.4% FY 2025
ROIC -272.9%
FY 2014: -49.3%FY 2015: -172.6%FY 2016: -26.3%FY 2017: -76.3%FY 2018: -160.1%FY 2019: -141.5%FY 2020: -68.7%FY 2024: -908.4%FY 2025: -272.9%
FY 2014 5y median -160.1% FY 2025
ROA -161.3%
FY 2014: -47.7%FY 2015: -109.4%FY 2016: -26.0%FY 2017: -65.5%FY 2018: -123.0%FY 2019: -116.1%FY 2020: -116.2%FY 2024: -148.8%FY 2025: -161.3%
FY 2014 5y median -123.0% FY 2025

Growth (YoY)

Revenue -96.0%
FY 2014: 0.0%FY 2015: 14.1%FY 2016: -16.0%FY 2017: 192.2%FY 2018: -8.2%FY 2019: -63.9%FY 2020: -51.6%FY 2024: 0.0%FY 2025: -96.0%
FY 2014 FY 2025
Operating Income -55.2%
FY 2014: 0.0%FY 2015: -51.8%FY 2016: -30.6%FY 2017: -76.3%FY 2018: -7.5%FY 2019: 37.2%FY 2020: 54.2%FY 2024: 0.0%FY 2025: -55.2%
FY 2014 FY 2025
EPS (diluted) 100.0%
FY 2014: 0.0%FY 2015: -68.8%FY 2016: 24.0%FY 2017: -58.8%FY 2018: 5.6%FY 2019: 74.4%FY 2020: 68.4%FY 2024: 0.0%FY 2025: 100.0%
FY 2014 FY 2025
Free Cash Flow 100.0%
FY 2014: 0.0%FY 2015: -13.3%FY 2016: -71.0%FY 2017: -60.6%FY 2018: 3.0%FY 2019: 24.9%FY 2020: 54.1%FY 2024: 0.0%FY 2025: 100.0%
FY 2014 FY 2025

Financial Health

Current Ratio 2.0×
FY 2014: 23.2×FY 2015: 2.5×FY 2016: 17.0×FY 2017: 5.2×FY 2018: 1.7×FY 2019: 4.6×FY 2020: 1.6×FY 2024: 0.9×FY 2025: 2.0×
FY 2014 5y median 1.7× FY 2025
Quick Ratio 2.0×
FY 2014: 22.7×FY 2015: 2.4×FY 2016: 16.8×FY 2017: 5.0×FY 2018: 1.6×FY 2019: 4.1×FY 2020: 1.6×FY 2024: 0.4×FY 2025: 2.0×
FY 2014 5y median 1.6× FY 2025
Debt / Equity 0.0×
FY 2014: -0.1×FY 2015: -0.2×FY 2016: 0.2×FY 2017: 0.3×FY 2018: 0.8×FY 2019: 0.1×FY 2020: 2.2×FY 2024: -3.8×FY 2025: 0.0×
FY 2014 5y median 0.1× FY 2025
Net Debt / EBITDA 0.5×
FY 2014: 0.2×FY 2015: -0.4×FY 2016: 3.0×FY 2017: 0.3×FY 2018: 0.3×FY 2019: 0.6×FY 2020: -0.6×FY 2024: 12.5×FY 2025: 0.5×
FY 2014 5y median 0.5× FY 2025
Interest Coverage 70.6×
FY 2014: 0.0×FY 2015: 0.0×FY 2016: 0.0×FY 2017: 0.0×FY 2018: 0.0×FY 2019: 0.0×FY 2020: 0.0×FY 2024: 0.0×FY 2025: 70.6×
FY 2014 5y median 0.0× FY 2025

Dividends

Dividend Yield 0.0%
FY 2014: 0.0%FY 2015: 0.0%FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2014 5y median 0.0% FY 2025
Payout Ratio 0.0%
FY 2014: 0.0%FY 2015: 0.0%FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2014 5y median 0.0% FY 2025

Annual · latest fiscal year ends 2025-12-31